PER-012-99Completed未知
TOPICAL TREATMENT OF CUTANEOUS LESHMANIASIS WITH ALDARA
IVERSIDAD PERUANA CAYETANO HEREDIA,0 sites0 target enrollmentStarted: September 30, 1999Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 0 to 0 (—)
Inclusion Criteria
- •(1) Patients with cutaneous leishmaniasis with parasitological demonstration,
- •(2) Both sexes,
- •(3) Age: 14 years or older.
Exclusion Criteria
- •(1) Under 14 years old,
- •(2) Injuries located on the face or on joints,
- •(3) Injuries with areas larger than 25 cm
- •(4) Pregnant women or women who are breastfeeding (the first three months),
- •(5) Be carriers of a systemic disease,
- •(1) Guests immuno compromised
Investigators
Similar Trials
Completed
Not Applicable
TREATMENT OF LESHMANIASIS CUTAENA PERUANA WITH PENTAMIDINE ISETIONATE (WR 179745) USING MEGLUMIN ANTIMONIATE AS A POSITIVE CONTROL: A PHASE III B STUDYLeishmaniasisPER-057-00IVERSIDAD PERUANA CAYETANO HEREDIA,
Recruiting
Not Applicable
Treatment of Lambert-Eaton myasthenic syndrome with 3,4-diaminopyridiambert-Eaton myasthenic syndromeJPRN-UMIN000024055Tokushima University10
Completed
Phase 2
Treatment of Lambert-Eaton myasthenic syndrome with 3,4-diaminopyridiambert-Eaton myasthenic syndromeJPRN-UMIN000004795Fukushima Medical University5
Recruiting
Phase 2
Treatment of cutaneous leishmaniasis with thymol loaded chitosan gelIRCT20180526039848N1Mashhad University of Medical Sciences50
Completed
Phase 2
Evaluation of the treatment of cutaneous leishmaniasis with Epigallocatechin Gallatecutaneous leishmaniasis.Cutaneous leishmaniasisB55.1IRCT20180526039848N2Mashhad University of Medical Sciences40